NDC 0023-3616

LATISSE

Bimatoprost

LATISSE is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Bimatoprost.

• Product ID: 0023-3616_476e4325-4bd9-4086-be6b-b9044c57e480
• NDC: 0023-3616
• Product Type: Human Prescription Drug
• Proprietary Name: LATISSE
• Generic Name: Bimatoprost
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2009-01-26
• Marketing Category: NDA / NDA
• Application Number: NDA022369
• Labeler Name: Allergan, Inc.
• Substance Name: BIMATOPROST
• Active Ingredient Strength: 0 mg/mL
• Pharm Classes: Prostaglandin Analog [EPC],Prostaglandins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0023-3616-03

1 BOTTLE, DROPPER in 1 CARTON (0023-3616-03) > 3 mL in 1 BOTTLE, DROPPER

• Marketing Start Date: 2009-01-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0023-3616-70 [00023361670]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-01-26

NDC 0023-3616-16 [00023361616]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-01-26

NDC 0023-3616-05 [00023361605]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-01-26

NDC 0023-3616-80 [00023361680]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-01-26

NDC 0023-3616-15 [00023361615]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2012-08-02
• Marketing End Date: 2013-01-07

NDC 0023-3616-04 [00023361604]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-01-26

NDC 0023-3616-03 [00023361603]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-01-26

NDC 0023-3616-81 [00023361681]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-01-26

NDC 0023-3616-71 [00023361671]

LATISSE SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA022369
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-01-26

Drug Details

Active Ingredients

Ingredient	Strength
BIMATOPROST	.3 mg/mL

OpenFDA Data

• SPL SET ID: 34f83d9d-2c64-463e-8a90-9a460fedfead
• Manufacturer:
  • Allergan, Inc.
• UNII:
  • QXS94885MZ
• RxNorm Concept Unique ID - RxCUI:
  • 1041497
  • 1041495
• PHarm Class EPC:
  • Prostaglandin Analog [EPC]
• NUI Code:
  • N0000175454
  • N0000007706

Pharmacological Class

• Prostaglandin Analog [EPC]
• Prostaglandins [Chemical/Ingredient]
• Prostaglandins [CS]
• Prostaglandin Analog [EPC]
• Prostaglandins [CS]

NDC Crossover Matching brand name "LATISSE" or generic name "Bimatoprost"

NDC	Brand Name	Generic Name
0023-3616	LATISSE	bimatoprost
0781-6206	Bimatoprost	Bimatoprost
42571-128	BIMATOPROST	BIMATOPROST
50383-908	Bimatoprost	Bimatoprost
50383-912	Bimatoprost	Bimatoprost
57297-429	bimatoprost	bimatoprost
60505-0583	Bimatoprost	Bimatoprost
62332-507	Bimatoprost	Bimatoprost
62332-511	bimatoprost	bimatoprost
65862-802	Bimatoprost	Bimatoprost
68083-295	Bimatoprost	Bimatoprost
68083-296	Bimatoprost	Bimatoprost
68083-439	Bimatoprost	Bimatoprost
0023-9652	DURYSTA	bimatoprost
0023-3205	LUMIGAN	bimatoprost